Publication: Is running associated with a lower risk of all-cause, cardiovascular and cancer mortality, and is the more the better? A systematic review and meta-analysis
dc.contributor.author | Zeljko Pedisic | en_US |
dc.contributor.author | Nipun Shrestha | en_US |
dc.contributor.author | Stephanie Kovalchik | en_US |
dc.contributor.author | Emmanuel Stamatakis | en_US |
dc.contributor.author | Nucharapon Liangruenrom | en_US |
dc.contributor.author | Jozo Grgic | en_US |
dc.contributor.author | Sylvia Titze | en_US |
dc.contributor.author | Stuart J.H. Biddle | en_US |
dc.contributor.author | Adrian E. Bauman | en_US |
dc.contributor.author | Pekka Oja | en_US |
dc.contributor.other | Victoria University Melbourne, Institute for Health and Sport | en_US |
dc.contributor.other | The University of Sydney | en_US |
dc.contributor.other | Karl-Franzens-Universitat Graz | en_US |
dc.contributor.other | University of Southern Queensland | en_US |
dc.contributor.other | UKK Institute Finland | en_US |
dc.contributor.other | Mahidol University | en_US |
dc.date.accessioned | 2020-01-27T08:50:58Z | |
dc.date.available | 2020-01-27T08:50:58Z | |
dc.date.issued | 2019-01-01 | en_US |
dc.description.abstract | © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. Objective: To investigate the association of running participation and the dose of running with the risk of all-cause, cardiovascular and cancer mortality. Design: Systematic review and meta-analysis. Data sources: Journal articles, conference papers and doctoral theses indexed in Academic Search Ultimate, CINAHL, Health Source: Nursing/Academic Edition, MasterFILE Complete, Networked Digital Library of Theses and Dissertations, Open Access Theses and Dissertations, PsycINFO, PubMed/MEDLINE, Scopus, SPORTDiscus and Web of Science. Eligibility criteria for selecting studies: Prospective cohort studies on the association between running or jogging participation and the risk of all-cause, cardiovascular and/or cancer mortality in a non-clinical population of adults were included. Results: Fourteen studies from six prospective cohorts with a pooled sample of 232 149 participants were included. In total, 25 951 deaths were recorded during 5.5-35 year follow-ups. Our meta-analysis showed that running participation is associated with 27%, 30% and 23% lower risk of all-cause (pooled adjusted hazard ratio (HR)=0.73; 95% confidence interval (CI) 0.68 to 0.79), cardiovascular (HR=0.70; 95% CI 0.49 to 0.98) and cancer (HR=0.77; 95% CI 0.68 to 0.87) mortality, respectively, compared with no running. A meta-regression analysis showed no significant dose-response trends for weekly frequency, weekly duration, pace and the total volume of running. Conclusion: Increased rates of participation in running, regardless of its dose, would probably lead to substantial improvements in population health and longevity. Any amount of running, even just once a week, is better than no running, but higher doses of running may not necessarily be associated with greater mortality benefits. | en_US |
dc.identifier.citation | British Journal of Sports Medicine. (2019) | en_US |
dc.identifier.doi | 10.1136/bjsports-2018-100493 | en_US |
dc.identifier.issn | 14730480 | en_US |
dc.identifier.issn | 03063674 | en_US |
dc.identifier.other | 2-s2.0-85074801311 | en_US |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/50974 | |
dc.rights | Mahidol University | en_US |
dc.rights.holder | SCOPUS | en_US |
dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85074801311&origin=inward | en_US |
dc.subject | Health Professions | en_US |
dc.title | Is running associated with a lower risk of all-cause, cardiovascular and cancer mortality, and is the more the better? A systematic review and meta-analysis | en_US |
dc.type | Review | en_US |
dspace.entity.type | Publication | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85074801311&origin=inward | en_US |